[Clinical use of Cordarone].
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001572:Benzofurans / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced; D009200:Myocardial Contraction / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010276:Parasympatholytics; D013329:Structure-Activity Relationship; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013961:Thyroid Gland / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001572:Benzofurans; D010276:Parasympatholytics; D014665:Vasodilator Agents; D000638:Amiodarone
Klinicheskoe primenenie kordarona.